The ONE InstantCare for COVID-19 Rapid Screening
SpectroChip Inc.
The ONE InstantCare for COVID-19 Rapid Screening
SpectroChip Inc.
Back to Hall of Fame
The ONE InstantCare developed by
SpectroChip uses its own “Spectral
Chip” technology to achieve a
quantitative analysis of antibody/
antigen. It is an important technology
that can achieve trace amounts and
quantitative tests for COVID-19 rapid
tests. The test process only takes
15 minutes to complete, and the
data can be uploaded to the cloud
database.
For suspected COVID-19 patients,
home isolation or follow-up of
confirmed patients, rapid screening
can help clarify the cause of the
patient, reduce the time of the
staying in hospitals, and serve
as a reference for whether it is
suitable for discharge. In the future,
relevant medical research and field
applications can be carried out on
a larger scale, which will help to a
certain extent on issues such as
epidemic control and community
prevention.
Highlights
- Rapid & Easy Test: It takes only about 15 minutes from sampling to get rapid quantitative results, and send the data to the cloud, with the easy operation of the mobile App.
- Accurate & High Sensitivity: Ability to accurately quantify antibodies (lgG/IgM) result, with a sensitivity of more than 200 times that of the existing rapid screening test, which can eliminate most false negatives and misjudgments.
- Cost Saving: Save time and cost by using rapid test strips and save medical resources for self-inspection.
- Wide Range of Application: COVID-19 antigen, IgM/IgG antibody, neutralising antibody can all be detected, and in the future, various detectors can also be developed in a wide range of applications such as telemedicine, home medical care, food safety, and industrial safety.
View Website
Back to Hall of Fame
The ONE InstantCare developed by
SpectroChip uses its own “Spectral
Chip” technology to achieve a
quantitative analysis of antibody/
antigen. It is an important technology
that can achieve trace amounts and
quantitative tests for COVID-19 rapid
tests. The test process only takes
15 minutes to complete, and the
data can be uploaded to the cloud
database.
For suspected COVID-19 patients,
home isolation or follow-up of
confirmed patients, rapid screening
can help clarify the cause of the
patient, reduce the time of the
staying in hospitals, and serve
as a reference for whether it is
suitable for discharge. In the future,
relevant medical research and field
applications can be carried out on
a larger scale, which will help to a
certain extent on issues such as
epidemic control and community
prevention.
Highlights
- Rapid & Easy Test: It takes only about 15 minutes from sampling to get rapid quantitative results, and send the data to the cloud, with the easy operation of the mobile App.
- Accurate & High Sensitivity: Ability to accurately quantify antibodies (lgG/IgM) result, with a sensitivity of more than 200 times that of the existing rapid screening test, which can eliminate most false negatives and misjudgments.
- Cost Saving: Save time and cost by using rapid test strips and save medical resources for self-inspection.
- Wide Range of Application: COVID-19 antigen, IgM/IgG antibody, neutralising antibody can all be detected, and in the future, various detectors can also be developed in a wide range of applications such as telemedicine, home medical care, food safety, and industrial safety.